TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharmaq Analytiq AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
86,743
|
78,737
|
82,604 |
Financial expenses |
544
|
486
|
82 |
Earnings before taxes |
-700
|
-6,379
|
-3,861 |
Total assets |
40,398
|
50,285
|
57,212 |
Current assets |
18,873
|
26,763
|
30,293 |
Current liabilities |
19,852
|
29,002
|
36,541 |
Equity capital |
20,326
|
20,862
|
20,256 |
- share capital |
1,100
![]() |
1,100
![]() |
1,100 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
50.3%
|
41.5%
|
35.4% |
Turnover per employee | |||
Profit as a percentage of turnover |
-0.8%
|
-8.1%
|
-4.7% |
Return on assets (ROA) |
-0.4%
|
-11.7%
|
-6.6% |
Current ratio |
95.1%
|
92.3%
|
82.9% |
Return on equity (ROE) |
-3.4%
|
-30.6%
|
-19.1% |
Change turnover |
8,006
|
-3,867
|
27,237 |
Change turnover % |
10%
|
-5%
|
49% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.